Moderna (MRNA) Exchange Rate Effect (2024 - 2026)
Moderna (MRNA) posted quarterly Exchange Rate Effect of -$2.0 million for Q2 2026, down 300.0% year-over-year from $1.0 million in Q2 2025, and down 300.0% on a QoQ basis from $1.0 million in Q1 2026.
Moderna (MRNA) Exchange Rate Effect (2024 - 2026) Analysis & Trends
Moderna has reported Exchange Rate Effect for 3 years, with the latest figure at -$2.0 million in Q2 2026.
- Exchange Rate Effect for Q2 2026 came in at -$2.0 million, down 300.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.0 million (changed N/A YoY), and the FY2025 annual result was $2.0 million, changed N/A from the prior year.
- Exchange Rate Effect fell to -$2.0 million in Q2 2026, from $1.0 million in the prior quarter.
- Over five years, Exchange Rate Effect peaked at $1.0 million in Q3 2024 and troughed at -$2.0 million in Q2 2026.
- A 3-year average of $166666.7 and a median of $1.0 million in 2024 frame the typical range for Exchange Rate Effect.
- The widest annual swing landed in 2025, when Exchange Rate Effect changed 0.0%; it then plunged 300.0% in 2026.
- A 3-year view of Exchange Rate Effect shows it stood at -$1.0 million in 2024, then surged by 200.0% to $1.0 million in 2025, then plunged by 300.0% to -$2.0 million in 2026.
- Per Business Quant data, the three most recent Exchange Rate Effect figures were -$2.0 million in Q2 2026, $1.0 million in Q1 2026, and $1.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 19.84 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -14,590.12 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -2.45 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -287,000.00 |
| 10 | Moderna | 25.26 Bn | 20.13 Bn | 52.00 Mn | -2.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2.00 Mn |
| Jun 30, 2026 | -2.00 Mn |
| Mar 31, 2026 | 1.00 Mn |
| Mar 31, 2026 | 1.00 Mn |
| Sep 30, 2025 | 1.00 Mn |
| Sep 30, 2025 | 1.00 Mn |
| Jun 30, 2025 | 1.00 Mn |
| Jun 30, 2025 | 1.00 Mn |
| Dec 31, 2024 | -1.00 Mn |
| Dec 31, 2024 | -1.00 Mn |
| Sep 30, 2024 | 1.00 Mn |
| Sep 30, 2024 | 1.00 Mn |